Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oralair (300 IR SLIT) for grass pollen rhinoconjunctivitis
NCT00803244Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Jan 2009
- Primary completion
- Aug 2009
- Modality
- Allergy Immunotherapy
- Countries
- 3
01
Overview
A Phase 3 trial of Oralair in allergic rhinoconjunctivitis (ARC), sponsored by Stallergenes Greer. Started Jan 2009; status: completed.
02
Drugs
Oralair
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00803244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803244.